Naltrexone implant - Indevus

Drug Profile

Naltrexone implant - Indevus

Alternative Names: VP 004

Latest Information Update: 07 Jul 2009

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Valera Pharmaceuticals
  • Class Analgesics; Cyclopropanes; Drug withdrawal therapies; Irritable bowel syndrome therapies; Morphinans; Small molecules
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Opioid abuse

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Mar 2009 Discontinued - Phase-I for Opioid abuse in USA (SC)
  • 23 Mar 2009 Indevus Pharmaceuticals has been acquired by Endo Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top